SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-347842
Filing Date
2018-12-12
Accepted
2018-12-12 16:55:56
Documents
4
Period of Report
2018-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d670386d8k.htm 8-K 19170
2 EX-5.1 d670386dex51.htm EX-5.1 8864
3 EX-10.1 d670386dex101.htm EX-10.1 166896
4 GRAPHIC g670386g1212012337804.jpg GRAPHIC 2534
  Complete submission text file 0001193125-18-347842.txt   199688
Mailing Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35670 | Film No.: 181231357
SIC: 2834 Pharmaceutical Preparations